OS Therapies Incorporated
OSTX
$1.86
$0.031.64%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -90.28% | -168.17% | -350.01% | -139.27% | -191.27% |
| Total Depreciation and Amortization | 11.02% | 17,742.86% | 8,821.43% | -- | 15,971.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 123.96% | 135.12% | 431.68% | -- | 205.94% |
| Change in Net Operating Assets | 10.04% | 1,407.99% | 2,121.92% | 217.25% | 769.20% |
| Cash from Operations | -134.42% | -32.59% | -57.09% | -39.04% | -167.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 94.10% | -- | -- | 19.87% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -1,543.06% | -- |
| Cash from Financing | 94.06% | 394.90% | -64.90% | -26.56% | 183.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -321.60% | 125.28% | -143.72% | -152.48% | -3,088.68% |